Tempest Therapeutics, Inc. ( TPST) - Key Metrics
TPST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.34 | -$0.18 | -$0.18 |
| 2026Q1 | $0 | -$2.53 | -$0.70 | -$0.70 |
| 2025Q4 | $0 | -$0.97 | -$0.86 | -$0.86 |
| 2025Q3 | $0 | -$0.79 | -$1.53 | -$1.53 |
| 2025Q2 | $0 | -$2.07 | -$2.22 | -$2.22 |
TPST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.82 |
| 2026Q1 | 0% | -0.16 |
| 2025Q4 | 0% | -0.88 |
| 2025Q3 | 0% | -3.25 |
| 2025Q2 | 0% | -0.82 |
TPST
Price: $1.07
52 week price:
Earnings Per Share: -5.70 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 5600
Market Capitalization: 16.2 million